Body Mass Index and Obesity Surgery Mortality Risk Score in Perioperative Complications of Laparoscopic Sleeve Gastrectomy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1617 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-01-01

Study Completion Date

2019-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The term obesity is defined as body mass index (BMI) 30 and over, and morbid obesity is considered as BMI greater than 40 (1).Its incidence in the general population is approximately 20% according to Organisation for data of Economic Co-operation and Development (OECD) countries and unfortunately, it is increasing worldwide (2). Obesity should not be thought ofas a single disorderasit is related tomany disorders like hypertension, diabetes, obstructive sleep apnea, cardiovascular diseases, and increased risk of malignancies (1).For years people have struggled with obesitywithboth metabolic and physical problems. Surgical treatment is the most effective long-term therapeutic treatment in current and modern medicine of obesity and obesity-related diseases as the last resort.(3-5). Roux-en-y gastrojejunostomy is the method that has been applied for many years and there isconsensus on its effect.However, in recent years, laparoscopic sleeve gastrectomy (LSG) has an increasing number of procedures with a short learning curve and it is the most performed surgical technique all over the world and also in Turkey (2,6).

Unfortunately, like any surgical procedure, this surgery has its own complications.Although being performed frequently increases the experience of surgeons, this situation cannot reduce the risk of complications of surgery to zero. In morbid obesity patients, the risk of any complications in all surgical procedures is higher than withother patients who were not morbidly obese. Due to these complications, prolonged hospital stays, increased reapplications to the hospital, reoperations and deaths can result(5,7). Despite both an increased risk of complications according to obesity and the risk of specific complications due to sleeve gastrectomy, laparoscopic sleeve gastrectomy is associated with acceptable postoperative morbidity and mortality rates (8).

Various classifications have been described in the literature for complications after surgery.In one of these classifications, according to Clavien-Dindo (CD) Classification, complications are divided into two groups as major and minor. (1, 9)(Table 1). This classification can be applied to bariatric and metabolic surgeries as withall surgery types. Especially major complications in this classification are life-threatening situations and their early detection is important (8).

In fact, surgeons do not want to encounter mortality in any of their patients. In this respect, DeMaria et al. developed an easily applicable mortality risk scoring system, which is consisted of five items (age ≥45 years, male sex, body mass index (BMI) ≥ 50 kg / m2, arterial hypertension, and risk factors for pulmonary thromboembolism) and can be used for the pre-operative determination of risky patients in obesity surgery(Obesity Surgery Mortality Risk Score; OR-MRS) (8,10,11).

In this study, it is aimed to determine the perioperative complications seen in the laparoscopic sleeve gastrectomy patients that we performed in our clinic without being discharged from the hospital and to evaluate the treatment processes of the complications under literature. In addition, whether the OS-MRS risk assessment scale and BMI had a role indetermining perioperative complications before discharge was investigated.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pan Immune Inflammation Value for Perioperative Complications of Laparoscopic Sleeve Gastrectomy

NCT06284356

Morbid Obesity Laparoscopic Sleeve Gastrectomy Post Operative Complicaiton

COMPLETED

Istmin Levels in Laparoscopik Sleeve Gastrectomy

NCT07335549

Obesity & Overweight Sleeve Gastrectomy Adipokines

COMPLETED

Laparoscopic Sleeve Gastrectomy in Severely Obese Adolescents: Effects on Metabolism

NCT02594514

Obesity Surgery

COMPLETED

The Effect of Laparoscopic Sleeve Gastrectomy on Blood Phoenixin-14 Levels

NCT07004556

Obesity, Morbid Obesity and Overweight

COMPLETED

Anesthetics and Cerebral Oxygenation in LSG

NCT03946657

Morbid Obesity Bariatric Surgery Candidate Anesthesia

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Material - Method Our study was carried out with the approval numbered 13281952-929 from Elazig Training and Research Hospital. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. 1752 patients who met the criteria of patient selection in terms of obesity and metabolic disease surgery, operated in the Elazığ Training and Research Hospital General Surgery Clinic between January 2016 and October 2018 were evaluated retrospectively. Patients' data were obtained from epicrisis forms in the hospital computer system, patient follow-up charts and patient files. Data for OS-MRS and Clavien Dindo complication classification were obtained from patient follow-up charts, patient files and hospital computer records. Patients' demographic data (age, sex), presence of comorbidities, complications (wound complications, thromboembolic events, leakage from anastomosis, splenic infarction proven by imaging methods, bleeding detected due to low hemoglobin and hematocite values during follow-up, acute renal failure due to deterioration in biochemical parameters) seen in follow up period before discharge (postoperative first 72 hours), complication type (major and minor), whether emergency surgery was performed, BMI values, postoperative hospitalization and OS-MRS. Additionally, while grouping according to BMI values, patients with BMI values below 40 were excluded and three groups with BMI values of 40 - 45 kg / m\^2, 45 - 50 kg / m\^2 and 50 kg / m\^2 and above were created. It was investigated whether there were any complications among these groups and the presence of major or minor complications by CD classification. 1617 patients who met the inclusion criteria were evaluated.

IBM Statistical Package for Social Sciences (SPSS) 20.0 was used for statistical evaluation. Kolmogorow-Smirnov test results were examined in terms of the suitability of the groups for normal distribution. In comparisons between groups, independent sample t-test or Mann Whitney U test was used to evaluate numerical data according to normality test. In the evaluation of categorical data, chi-square analysis and Fischer's exact test were performed. In terms of the relation between complication formation and BMI, univariate analysis and multivariate analysis were performed. Numerical data were given as mean ± standard deviation (ss) (minimum - maximum values) or median (minimum - maximum values) according to normality test. Categorical data are given as count (n) and percentage (%).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Perioperative Complication Laparascopic Sleeve Gastrectomy BMD Obesity, Morbid Obesity Surgery Mortality Score Clavien Dindo Surgical Complication Scale

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Complication positive

Patients with perioeprative complications after laparascopic sleeve gastrectomy before discharge (wound complications, thromboembolic events, staple line leakage, splenic infarction proven by imaging modalities, bleeding detected due to low hemoglobin and hematocrit values during follow-up, acute renal failure due to deterioration in biochemical parameters)

Laparascopic Sleeve Gastrectomy

Intervention Type PROCEDURE

Operations performed for complciation of laparascopic sleeve gastrectomy

İnterventional radiologic drainage

Intervention Type PROCEDURE

İnterventional radiologic drainage of gastric leakage

Complte Blood Count and Biochemical evaluation

Intervention Type DIAGNOSTIC_TEST

blood samples obtained from patients to determine the hgb and htc levels of patients and biochemical changes of patients after surgery

Computed tomography

Intervention Type DIAGNOSTIC_TEST

Admitted to observe leakage

Complication negative

Patients without perioeprative complications after laparascopic sleeve gastrectomy before discharge

Complte Blood Count and Biochemical evaluation

Intervention Type DIAGNOSTIC_TEST

blood samples obtained from patients to determine the hgb and htc levels of patients and biochemical changes of patients after surgery

BMI 40 - 45 kg/m2

Operated patients preoperative BMI values between 40 - 45 kg/m2

Complte Blood Count and Biochemical evaluation

Intervention Type DIAGNOSTIC_TEST

blood samples obtained from patients to determine the hgb and htc levels of patients and biochemical changes of patients after surgery

BMI 45 - 50 kg/m2

Operated patients preoperative BMI values between 45 - 50 kg/m2

Complte Blood Count and Biochemical evaluation

Intervention Type DIAGNOSTIC_TEST

blood samples obtained from patients to determine the hgb and htc levels of patients and biochemical changes of patients after surgery

BMI over 50 kg/m2

Operated patients preoperative BMI values 45 - 50 kg/m2

Complte Blood Count and Biochemical evaluation

Intervention Type DIAGNOSTIC_TEST

blood samples obtained from patients to determine the hgb and htc levels of patients and biochemical changes of patients after surgery

Clavien Dindo Major Complications

1. Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and radiological interventions Acceptable therapeutic regimens are: drugs as antiemetics, antipyretics, analgesics, diuretics and electrolytes and physiotherapy This grade also includes wound infections opened at the bedside
2. Requiring pharmacological treatment with drugs other than such allowed for grade I complications. Blood transfusions, antibiotics and total parenteral nutrition are also included

Laparascopic Sleeve Gastrectomy

Intervention Type PROCEDURE

Operations performed for complciation of laparascopic sleeve gastrectomy

İnterventional radiologic drainage

Intervention Type PROCEDURE

İnterventional radiologic drainage of gastric leakage

Complte Blood Count and Biochemical evaluation

Intervention Type DIAGNOSTIC_TEST

blood samples obtained from patients to determine the hgb and htc levels of patients and biochemical changes of patients after surgery

Computed tomography

Intervention Type DIAGNOSTIC_TEST

Admitted to observe leakage

Clavien Dindo Minor Complciations

3\. Requiring surgical, endoscopic or radiological intervention 3a Intervention under regional/local anaesthesia 3b Intervention under general anaesthesia 4. Life-threatening complication requiring intensive care/intensive care unit management 4a Single-organ dysfunction 4b Multi-organ dysfunction 5. Patient demise

İnterventional radiologic drainage

Intervention Type PROCEDURE

İnterventional radiologic drainage of gastric leakage

Complte Blood Count and Biochemical evaluation

Intervention Type DIAGNOSTIC_TEST

blood samples obtained from patients to determine the hgb and htc levels of patients and biochemical changes of patients after surgery

Computed tomography

Intervention Type DIAGNOSTIC_TEST

Admitted to observe leakage

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Laparascopic Sleeve Gastrectomy

Operations performed for complciation of laparascopic sleeve gastrectomy

Intervention Type PROCEDURE

İnterventional radiologic drainage

İnterventional radiologic drainage of gastric leakage

Intervention Type PROCEDURE

Complte Blood Count and Biochemical evaluation

blood samples obtained from patients to determine the hgb and htc levels of patients and biochemical changes of patients after surgery

Intervention Type DIAGNOSTIC_TEST

Computed tomography

Admitted to observe leakage

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Reoperation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients whose data was available
* Morbid obesity patients who were operated with surgical technique laparoscopic sleeve gastrectomy

Exclusion Criteria

* Patients whose data was not available
* Patients who were operated with other types of bariatric metabolic surgery
* Patients who left the hospital due to referral
* Patients whose OS-MRS scale wasn't calculated
* Patients whose American Society of Anesthesiologists (ASA) score was 4 or greater

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes